title: Extra-pulmonary Reactivation of Latent Tuberculosis After Initiation of Anti-tumour Necrosis Factor Therapy for Inflammatory Bowel Disease-Are Current Screening Strategies Adequate?
authors.affiliation: Department of Gastroenterology, Kingston Hospital, Kingston upon Thames, UK.
authors.forename: Thomas H
authors.initials: TH
authors.lastname: Tranah
authors.affiliation: Department of Gastroenterology, Kingston Hospital, Kingston upon Thames, UK.
authors.forename: Shin Y
authors.initials: SY
authors.lastname: Luk
authors.affiliation: Department of Gastroenterology, Kingston Hospital, Kingston upon Thames, UK.
authors.forename: Markus
authors.initials: M
authors.lastname: Gess
mesh_terms: D000068879:Adalimumab / Q000008:administration & dosage / Q000009:adverse effects*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects; D000995:Antitubercular Agents / Q000008:administration & dosage*; D001201:Ascites / Q000000981:diagnostic imaging / Q000209:etiology / Q000382:microbiology; D003106:Colon / Q000000981:diagnostic imaging / Q000473:pathology; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D055985:Latent Tuberculosis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D008403:Mass Screening / Q000379:methods; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification / Q000502:physiology; D011860:Radiography, Abdominal / Q000379:methods; D014057:Tomography, X-Ray Computed / Q000379:methods; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000893:Anti-Inflammatory Agents; D000995:Antitubercular Agents; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab